The specialized metabolism and trafficking of cellular subcompartments
Your first biology course probably defined eukaryotes in part as having a group of specialized organelles. These membrane-bound subcompartments of the eukaryotic cell are unique in many ways, especially their specialized biochemistry and metabolism.
The three sessions we have organized for Discover BMB will cover several topics focused on the novel biology and biochemistry of the mitochondria, peroxisome and chloroplast. These sessions will address current research on specific metabolic pathways, with important new insights into the protein structure and trafficking that support the integrity and function of these organelles.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
These multidisciplinary talks will provide information not only on the specific biochemical functions of these organelles, but also on their integrative architecture and physiology. In the three sessions, new information will be integrated into general principles of organelle biogenesis and metabolic function.
Keywords: Mitochondria, chloroplast, peroxisome, metabolism, covalent modifications, organelle biogenesis, protein structure and trafficking.
Who should attend: Anyone interested in metabolism, organellar proteomes and the specialized biology of organelles.
Theme song: “The Cell” by Gojira, because it is such a high-energy song — mitochondria, chloroplasts ...
This session is powered by ATP.
Mitochondria, peroxisomes and chloroplast metabolism
Protein covalent modifications and chloroplast metabolism
Chair: Greg Moorhead
Greg Moorhead, University of Calgary
Glen Uhrig, University of Alberta
R. Paul Jarvis, University of Oxford
Paula Mulo, University of Turku
Peroxisome biogenesis/metabolism
Chair: Tom Rapoport
Francesca Di Cara, Dalhousie University
Brooke Gardner, University of California, Santa Barbara
Tom Rapoport, Harvard Medical School; Howard Hughes Medical Institute
Irfan Lodhi, Washington University in St. Louis
Mitochondria energetics/metabolism
Chair: Erin Goley
Pere Puigserver, Dana–Farber Cancer Institute; Harvard Medical School
Lena Pernas, Max Planck Institute for Biology of Ageing
Alexey Amunts, Stockholm University
Rebecca Voorhees, California Institute of Technology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.
What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.
Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.
Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.
How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.
A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.